Compartir
Covid-19 Lung Disease: Lessons Learned, an Issue of Clinics in Chest Medicine (Volume 44-2) (The Clinics: Internal Medicine, Volume 44-2) (en Inglés)
Dela Cruz Charles S.,Cheng Guang-Shing (Autor)
·
Elsevier
· Tapa Dura
Covid-19 Lung Disease: Lessons Learned, an Issue of Clinics in Chest Medicine (Volume 44-2) (The Clinics: Internal Medicine, Volume 44-2) (en Inglés) - Dela Cruz Charles S.,Cheng Guang-Shing
S/ 395,23
S/ 790,47
Ahorras: S/ 395,23
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Reino Unido
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Miércoles 17 de Julio y el
Jueves 01 de Agosto.
Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.
Reseña del libro "Covid-19 Lung Disease: Lessons Learned, an Issue of Clinics in Chest Medicine (Volume 44-2) (The Clinics: Internal Medicine, Volume 44-2) (en Inglés)"
In this issue of Clinics in Chest Medicine, guest editors Drs. Drew Harris, Emily Brigham, and Juan Celedon bring their considerable expertise to the topic of Aiming to Improve Equity in Pulmonary Health. Top experts discuss disparities in risk factors for respiratory diseases, how communities are affected unequally, interventions to mitigate disparities, and evidence of effects, if present. Contains 17 practice-oriented topics including racism and bias, tobacco use, air pollution and climate change, occupational hazards, access to care and rural health, asthma and COPD, lung cancer, pulmonary hypertension, migrants and refugees, sex and gender, homelessness and incarceration, mental illness, and more. Provides in-depth clinical reviews of improving equity in pulmonary health, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
